senate Bill S6393

2021-2022 Legislative Session

Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors

download bill text pdf

Sponsored By

Current Bill Status - Passed Senate


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (16)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Mar 03, 2022 referred to higher education
delivered to assembly
passed senate
Feb 17, 2022 advanced to third reading
Feb 16, 2022 2nd report cal.
Feb 15, 2022 1st report cal.511
Jan 05, 2022 referred to higher education
returned to senate
died in assembly
Jun 02, 2021 referred to higher education
delivered to assembly
passed senate
May 24, 2021 advanced to third reading
May 20, 2021 2nd report cal.
May 18, 2021 1st report cal.1137
Apr 26, 2021 referred to higher education

Votes

view votes

Feb 15, 2022 - Higher Education committee Vote

S6393
11
0
committee
11
Aye
0
Nay
0
Aye with Reservations
0
Absent
0
Excused
0
Abstained
show Higher Education committee vote details

Higher Education Committee Vote: Feb 15, 2022

May 18, 2021 - Higher Education committee Vote

S6393
11
0
committee
11
Aye
0
Nay
0
Aye with Reservations
0
Absent
0
Excused
0
Abstained
show Higher Education committee vote details

Higher Education Committee Vote: May 18, 2021

Co-Sponsors

S6393 (ACTIVE) - Details

See Assembly Version of this Bill:
A3981
Current Committee:
Assembly Higher Education
Law Section:
Education Law
Laws Affected:
Amd §6816-a, Ed L
Versions Introduced in Other Legislative Sessions:
2015-2016: S8189
2017-2018: S2489, A7219
2019-2020: S3539, A1181

S6393 (ACTIVE) - Summary

Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors in certain cases.

S6393 (ACTIVE) - Sponsor Memo

S6393 (ACTIVE) - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   6393
 
                        2021-2022 Regular Sessions
 
                             I N  S E N A T E
 
                              April 26, 2021
                                ___________
 
 Introduced  by  Sen. REICHLIN-MELNICK -- read twice and ordered printed,
   and when printed to be committed to the Committee on Higher Education
 
 AN ACT to amend the education law, in relation to  the  substitution  of
   brand name epinephrine auto-injectors with alternate epinephrine auto-
   injectors for dispensation by pharmacists

   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Section 6816-a of the education law is amended by adding  a
 new subdivision 6 to read as follows:
   6.  (A)  NOTWITHSTANDING  SUBDIVISION TWO OF THIS SECTION OR ANY OTHER
 SECTION OF LAW TO THE CONTRARY, WHEN A PATIENT  IS  PRESCRIBED  A  BRAND
 NAME EPINEPHRINE AUTO-INJECTOR, A PHARMACIST MAY SUBSTITUTE AN ALTERNATE
 EPINEPHRINE AUTO-INJECTOR CONTAINING THE SAME ACTIVE INGREDIENTS, DOSAGE
 FORM  AND  STRENGTH  AS  THE  BRAND  NAME PRODUCT PRESCRIBED, ORDERED OR
 DEMANDED, REGARDLESS OF WHETHER THE ALTERNATE EPINEPHRINE  AUTO-INJECTOR
 IS  INCLUDED IN THE LATEST LIST OF INTERCHANGEABLE DRUG PRODUCTS FOR THE
 PRESCRIBED EPINEPHRINE AUTO-INJECTOR DEVICE, PROVIDED THAT:
   (I) THE PRESCRIBER DOES NOT INDICATE THAT  THE  PRESCRIPTION  THEREFOR
 SHALL  BE  DISPENSED AS WRITTEN PURSUANT TO PARAGRAPH (A) OF SUBDIVISION
 SIX OF SECTION SIXTY-EIGHT HUNDRED TEN OF THIS ARTICLE;
   (II) THE ALTERNATE EPINEPHRINE AUTO-INJECTOR AVAILABLE WOULD REFLECT A
 LOWER UNIT COST TO THE PURCHASER;
   (III) THE PHARMACIST HAS ADVISED THE PURCHASER OF THE AVAILABILITY  OF
 AN  ALTERNATE EPINEPHRINE AUTO-INJECTOR AND OBTAINED CONSENT TO DISPENSE
 THE ALTERNATE EPINEPHRINE AUTO-INJECTOR; AND
   (IV) THE PHARMACIST HAS COUNSELED THE PATIENT OR PERSON AUTHORIZED  TO
 ACT  ON  THE PATIENT'S BEHALF ON THE PROPER USAGE AND OPERATING FEATURES
 OF THE ALTERNATE EPINEPHRINE AUTO-INJECTOR.
   (B) FOR PURPOSES OF THIS SUBDIVISION "EPINEPHRINE AUTO-INJECTOR" SHALL
 HAVE THE SAME MEANING AS PROVIDED IN PARAGRAPH (B) OF SUBDIVISION ONE OF
 SECTION THREE THOUSAND-C OF THE PUBLIC HEALTH LAW.
   § 2. This act shall take effect immediately.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.